Being physically fit may improve survival rates among diabetes patients with a particular type of heart abnormality….
Read More »Yearly Archives: 2012
Insulin with Liraglutide Improves Poorly Controlled Type 1
Obese adults with poorly controlled type 1 diabetes can better control their blood sugar by adding liraglutide to their insulin therapy….
Read More »Weight Loss Aided in Diabetic Patients by Experimental Drug
An experimental drug helped significantly more overweight patients with diabetes shed pounds, compared with placebo….
Read More »Sitagliptin Improves Reactive Hypoglycemia Symptoms
The diabetes drug sitagliptin appears to reduce the severity of reactive hypoglycemia….
Read More »GLP-1: Actions on Beta-cell Mass and Function
David Joffe, BSPharm, CDE Tina Burge, PharmD Candidate Florida A&M University Kiet Ngo, Pharm D Candidate Mercer University Abnormalities in incretin hormones such as the glucagon-like peptide-1 (GLP-1) contribute to the development of hyperglycemia. GLP-1 was discovered as a peptide encoded by the proglucagon gene and was named glucagon-like because …
Read More »FDA Approves New Weight-Loss Drug
FDA Approves New Weight-Loss Drug The oral weight-loss drug lorcaserin hydrochloride (Belviq) has been approved as an adjunct to diet and exercise in obese patients as well as in those who are overweight and have at least one other weight-related disorder such as hypertension. See this week’s Item #2, FDA …
Read More »Letter from the Editor #632: New Weight Loss Drugs
This week the FDA approved the new weight loss drug lorcaserin. This is the first new drug for weight loss we have had approved in 13 years and early indications are that we will be seeing a lot of prescriptions in the near future. Although I agree that we need …
Read More »Periodontitis Associated with Development of TYPE 2 Diabetes and its Complications
Oral Disease TREATMENT Can Help Control High Glycemic Levels San Francisco, CA (June 6, 2008) – Critical links between periodontal (gum) disease and the development of type 2 diabetes, as well as the development and progression of its complications, were reported here today in the first ever symposium presented by …
Read More »The influence of diabetes on the periodontal tissues
Maria Emanuel Ryan, DDS, PhD; Oana Carnu, DMD; Angela Kamer, DMD, PhD The pathogenesis of periodontal disease is complex because it reflects a combination of the initiation and maintenance of the chronic inflammatory process by a diverse microbial flora and its numerous bacterial products. The subsequent host response to this infection mediates …
Read More »Editor’s Desk: More on ADA-EASD Guidelines
Over the past four weeks we have shared some fantastic Homerun Slides on the new ADA-EASD guidelines for diabetes care. This week, Dr. Richard S. Beaser from the Joslin Diabetes Center provides more details on the guidelines and their history — be sure to read his comments in this week’s …
Read More »
Diabetes In Control. A free weekly diabetes newsletter for Medical Professionals. News and information for Medical Professionals.